Cost-effectiveness in preventive cardiology

被引：0
|
作者：
Weintraub W.S. [1 ]
机构：
[1] Division of Cardiology, Emory Univ. School of Medicine, Emory Center for Outcomes Research, Atlanta, GA 30322, Briarcliff Campus
来源：
Current Treatment Options in Cardiovascular Medicine | 2004年 / 6卷 / 4期
关键词：
Smoking Cessation; Indirect Cost; Pravastatin; Bupropion; Eplerenone;
D O I：
10.1007/s11936-004-0030-7
中图分类号：
学科分类号：
摘要：
Cardiovascular disease remains a serious medical problem, which can be associated with death and disability on one hand, and considerable resource utilization on the other. The primary driver for choice of therapy must remain clinical efficacy. Once efficacy is established, cost-effectiveness analysis has an important role. Resources are limited, and responsible choices must be made. The methods involved in cost-effectiveness analysis are complicated and data for the analysis are generally not fully optimal. Nonetheless, cost-effectiveness analysis offers the best method for helping society make rational medical decisions. Effective interventions, when reasonably priced, for the prevention of cardiovascular disease have generally proven to be cost-effective. Copyright © 2004 by Current Science Inc.
引用
收藏
页码：279 / 290
页数：11
相关论文
共 50 条
  • [21] The Cost-Effectiveness of Preventive Interventions for Mental Disorders and Suicide
    Mihalopoulos, Cathrine
    Vos, Theo
    Pirkis, Jane
    Carter, Rob
    [J]. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2011, 14 : S22 - S22
  • [22] Cost-effectiveness of preventive interventions for depressive disorders: an overview
    Mihalopoulos, Cathrine
    Vos, Theo
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (02) : 237 - 242
  • [23] Considering Cost-Effectiveness in Cardiology Clinical Guidelines: Progress and Prospects
    Hlatky, Mark A.
    [J]. VALUE IN HEALTH, 2016, 19 (05) : 516 - 519
  • [24] The preventive Home Visit as a Preventive Intervention to Reach the Elderly Effectiveness and Cost-Effectiveness of Different Ways of Approach
    Patzelt, C.
    Deitermann, B.
    Heim, S.
    Lupp, K.
    Stahmeyer, J.
    Krauth, C.
    Theile, G.
    Hummers-Pradier, E.
    Walter, U.
    [J]. GESUNDHEITSWESEN, 2015, 77 : S45 - S46
  • [25] PREVENTIVE THERAPY WITH ISONIAZID - COST-EFFECTIVENESS OF DIFFERENT DURATIONS OF THERAPY
    SNIDER, DE
    CARAS, GJ
    KOPLAN, JP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (12): : 1579 - 1583
  • [26] Cost-effectiveness research on preventive interventions: a survey of the publications in 2008
    van Gils, Paul F.
    Tariq, Luqman
    Verschuuren, Marieke
    van den Berg, Matthijs
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2011, 21 (02): : 260 - 264
  • [27] METHODS FOR ASSESSING THE COST-EFFECTIVENESS OF CARIES PREVENTIVE AGENTS AND PROCEDURES
    HOROWITZ, HS
    HEIFETZ, SB
    [J]. INTERNATIONAL DENTAL JOURNAL, 1979, 29 (02) : 106 - 117
  • [28] COST-EFFECTIVENESS RESEARCH ON PREVENTIVE MEASURES: A SURVEY OF THE PUBLICATIONS IN 2008
    van Gils, P.
    Tariq, L.
    Verschuuren, M.
    Van den Berg, M.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A249 - A249
  • [29] Cost-effectiveness criteria for marine oil spill preventive measures
    Vanem, Erik
    Endresen, Oyvind
    Skjong, Rolf
    [J]. RELIABILITY ENGINEERING & SYSTEM SAFETY, 2008, 93 (09) : 1354 - 1368
  • [30] Preventive Antibiotics in Stroke Study (PASS) A cost-effectiveness study
    Westendorp, Willeke F.
    Zock, Elles
    Vermeij, Jan-Dirk
    Kerkhoff, Henk
    Nederkoorn, Paul J.
    Dijkgraaf, Marcel G. W.
    van de Beek, Diederik
    [J]. NEUROLOGY, 2018, 90 (18) : E1553 - E1560
12345